SCHEMBL21679696

SCHEMBL21679696

CCN(CC)CCC(=O)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.54
▸ POLB P06746 2/20 0.54
▸ LMNA P02545 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ FKBP1A P62942 4/20 0.45
▸ HTT P42858 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23771147 0.90 GLA (0.55) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL14079960 0.84 TSHR (0.53) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL30272382 0.81 TSHR (0.53) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL9715182 0.79 FKBP1A (0.46) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL84372 0.79 TSHR (0.62) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL14174871 0.77 NPC1 (0.62) POLBLMNAALDH1A1RAB9AHRH3
SCHEMBL9007157 0.77 HRH3 (0.44) TSHRPOLBLMNAALDH1A1L3MBTL1
SCHEMBL14174877 0.76 NPC1 (0.43) LMNAALDH1A1HSD17B10CYP3A4
SCHEMBL31749431 0.76 GNAI3 (0.58) LMNAALDH1A1L3MBTL1SMN1; SMN2HSD17B10
SCHEMBL14627468 0.76 ALDH1A1 (0.41) POLBLMNAALDH1A1L3MBTL1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117946032-A Novel efficient preparation method of acrylamide compound 深圳有为技术控股集团有限公司 2024-04-30 — — CN disclosed
CN-117777059-A Preparation method of acrylamide compound 深圳有为技术控股集团有限公司 2024-03-29 — — CN disclosed
CN-117050037-A Preparation method of acrylamide compound 深圳有为技术控股集团有限公司 2023-11-14 — — CN disclosed
CN-107417644-B Preparation method of acrylamide compound 深圳有为技术控股集团有限公司 2023-09-12 — — CN disclosed
CN-108164477-B Process for preparing mono-or polyfunctional acrylamide compounds 深圳有为技术控股集团有限公司 2023-05-16 — — CN disclosed
CN-108947937-B Co-production preparation method of acrylamide and formamide type compound 深圳有为技术控股集团有限公司 2023-05-16 — — CN disclosed
EP-3613727-B1 PREPARATION METHOD FOR CO-PRODUCING ACRYLAMIDE AND FORMAMIDE COMPOUNDS SHENZHEN UV CHEM TECH INC (CN) 2022-03-16 — — EP disclosed
CN-107973759-B Preparation method of acryloyl morpholine 湖南久日新材料有限公司 2021-03-05 — — CN disclosed
US-10647659-B2 Process for productions of formamides and acrylamides SHENZHEN YOUWEI TECHNOLOGY HOLDINGS GROUP CO., LTD. (CN) 2020-05-12 — — US disclosed
US-10647659-B2 Process for productions of formamides and acrylamides SHENZHEN YOUWEI TECHNOLOGY HOLDINGS GROUP CO., LTD. (CN) 2020-05-12 — — US disclosed
EP-3613727-A1 PREPARATION METHOD FOR CO-PRODUCING ACRYLAMIDE AND FORMAMIDE COMPOUNDS Shenzhen UV-Chem Tech Inc (CN) 2020-02-26 — — EP disclosed
EP-3613727-A1 PREPARATION METHOD FOR CO-PRODUCING ACRYLAMIDE AND FORMAMIDE COMPOUNDS Shenzhen UV-Chem Tech Inc (CN) 2020-02-26 — — EP disclosed
US-20200048186-A1 Process for Productions of Formamides and Acrylamides SHENZHEN YOUWEI TECHNOLOGY HOLDINGS GROUP CO.,LTD. (CN) 2020-02-13 — — US disclosed
US-20200048186-A1 Process for Productions of Formamides and Acrylamides SHENZHEN YOUWEI TECHNOLOGY HOLDINGS GROUP CO.,LTD. (CN) 2020-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647659-B2 Process for productions of formamides and acrylamides PFAS, FASN, AGPS TSHR 4795/4885POLB 2540/4885LMNA 3273/4885
US-20200048186-A1 Process for Productions of Formamides and Acrylamides PFAS, FASN, AGPS TSHR 4795/4885POLB 2540/4885LMNA 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback